Method for promoting the growth of probiotics

By combining the fermentation products of Lactobacillus salivary, Lactobacillus plantarum, Lactobacillus acidophilus and Bifidobacterium as culture medium, the problem of difficulty in promoting the growth of various probiotics in the prior art was solved, and a significant growth promotion effect was achieved. , better than the prebiotics that are known.

CN115960737BActive Publication Date: 2024-11-15锦乔生物科技有限公司
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202111187235.2
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2021-10-12
Publication Date
2024-11-15
Estimated Expiration
2041-10-12

AI Technical Summary

Technical Problem

The prior art is difficult to effectively promote the growth of various types of probiotics, and specific types of prebiotics can only exert growth-promoting effects on specific types of probiotics.

Method used

Lactobacillus salivarius subsp.salicinius AP-32, Lactobacillus plantarum LPL28, Lactobacillus acidophilus TYCA06 and Bifidobacterium longum subsp.infantis BLI- The fermentation product of 02 is promoted by combining the fermentation products of these lactic acid bacteria strains as culture medium.

Benefits of technology

It is significantly better than the common prebiotics, which can effectively promote the growth of various probiotics such as Lactobacillus, Lactococcus, Bifidobacteria, etc., improve growth efficiency, and can effectively promote one or more at different concentrations. The growth of probiotics replaces the prebiotics that are known.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN115960737B_ABST
    Figure CN115960737B_ABST
Patent Text Reader

Abstract

The present invention relates to a method for promoting the growth of probiotics. The present invention discloses a method for promoting the growth of probiotics, which comprises: culturing the probiotics in a culture medium containing a fermentation product of a lactic acid bacteria strain combination.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to methods for promoting the growth of probiotics. Background Art

[0002] Probiotics are live microbial food ingredients that are beneficial to health and can selectively stimulate the growth of native bacteria in the intestine. Probiotics have been found to have the effects of inhibiting the growth of gastrointestinal pathogens, alleviating lactose intolerance, immunoregulation, anti-cancer, and lowering blood pressure. Currently, the microorganisms known to be used as probiotics include species such as Lactobacillus, Bifidobacterium, Bacillus, Lactococcus, Enterococcus, Saccharomyces, and Streptococcus.

[0003] Prebiotics are polysaccharide and oligosaccharide compounds that cannot be digested by the human body. They can selectively promote the activity and growth of intestinal bacteria (especially probiotics). Common prebiotics include fructooligosaccharides, inulin, xylo-oligosaccharides, pectic oligosaccharides and palatinose.

[0004] Current studies have shown that certain types of prebiotics can only promote the growth of certain types of probiotics. R.et al.(2016),Int.J.Biol.Macromol.,89:669-676, R. et al. used inulin and palatinose to culture Lactobacillus casei A11, Lactobacillus paracasei B13, Lactococcus lactis subsp. lactis DSM 20729 and Lactobacillus acidophilus DSM20079, respectively. The experimental results showed that inulin could only promote the growth of Lactobacillus paracasei B13, while palatinose could not promote the growth of these probiotics.

[0005] Therefore, there is still a need in the art to develop methods that can effectively promote the growth of various probiotics. Summary of the invention

[0006] In the present invention, the applicant has found through experiments that the combined use of fermentation products of Lactobacillus salivarius subsp. salicinius AP-32 (CCTCC No.M 2011127), Lactobacillus plantarum LPL28 (CGMCC No.17954), Lactobacillus acidophilus TYCA06 (CGMCC No.15210) and Bifidobacterium longum subsp. infantis BLI-02 (CGMCC No.15212) can effectively promote the growth of various probiotics, and its efficacy is significantly better than that of conventional prebiotics.

[0007] Therefore, in a first aspect, the present invention provides a method for promoting the growth of probiotics, comprising: culturing the probiotics in a culture medium containing a fermentation product of a lactic acid bacteria strain combination, wherein the lactic acid bacteria strain combination comprises: Lactobacillus salivarius AP-32, Lactobacillus plantarum LPL28, Lactobacillus acidophilus TYCA06, and Bifidobacterium longum subspecies infantis BLI-02.

[0008] Preferably, the fermentation product is a liquid culture prepared by culturing Lactobacillus salivarius AP-32, Lactobacillus plantarum LPL28, Lactobacillus acidophilus TYCA06 and Bifidobacterium longum subsp. infantis BLI-02 with a bacterial count ratio falling within the range of 1:0.2:0.2:0.2 to 1:5:5:5.

[0009] Preferably, the bacterial count ratio is 1:1:1:1.

[0010] Preferably, the liquid culture is substantially free of bacterial cells after solid-liquid separation.

[0011] Preferably, the probiotic is selected from the group consisting of Lactobacillus spp., Lactococcus spp., Pediococcus spp., Enterococcus spp., Streptococcus spp., Bifidobacterium spp., Bacillus spp., Leuconostoc spp., and combinations thereof.

[0012] Preferably, the Lactobacillus species is selected from the group consisting of Lactobacillus gasseri, Lactobacillus fermentum, Lactobacillus johnsonii, Lactobacillus reuteri, Lactobacillus helveticus, Lactobacillus casei, Lactobacillus paracasei, Lactobacillus rhamnosus, Lactobacillus delbrueckii, Lactobacillus bulgaricus, Lactobacillus salivarius, Lactobacillus plantarum, Lactobacillus acidophilus, and combinations thereof.

[0013] Preferably, the Lactococcus species is Lactococcus lactis.

[0014] Preferably, the Streptococcus species is Streptococcus thermophilus.

[0015] Preferably, the Bifidobacterium species is selected from the group consisting of Bifidobacterium animalis, Bifidobacterium breve, Bifidobacterium longum, Bifidobacterium bifidum, Bifidobacterium lactis, Bifidobacterium adolescentis, Bifidobacterium infantis, and combinations thereof. BRIEF DESCRIPTION OF THE DRAWINGS

[0016] The present invention is described in detail below in conjunction with the accompanying drawings and embodiments, so the above and other objects and features of the present invention can be more clearly understood by referring to the following description, the claims attached hereto and the accompanying drawings, in which:

[0017] Figure 1 The relative growth multiples of each group of Lactobacillus rhamnosus MP108 after being treated with different lactic acid bacteria fermentation products are shown, where "*", "**" and "***" respectively indicate p < 0.05, p < 0.01 and p < 0.001 when compared with the control group;

[0018] Figure 2 The relative growth multiples of each group of Lactobacillus rhamnosus MP108 after being treated with lactic acid bacteria fermentation products and various prebiotics, where "*", "**" and "***" respectively indicate p < 0.05, p < 0.01 and p < 0.001 when compared with the control group;

[0019] Figure 3 The relative growth rates of each group of animal Bifidobacterium lactis subsp. CP-9 treated with lactic acid bacteria fermentation products and various prebiotics are shown, where "*" and "**" respectively indicate p<0.05 and p<0.01 when compared with the control group; and

[0020] Figure 4 The relative growth multiples of each group of mixed probiotics after being treated with lactic acid bacteria fermentation products and various prebiotics are shown, wherein "*" and "**" respectively indicate p < 0.05 and p < 0.01 when compared with the control group. DETAILED DESCRIPTION

[0021] For the purposes of this specification, it will be expressly understood that the word "comprising" means "including, but not limited to," and that the word "comprises" has a corresponding meaning.

[0022] Unless otherwise defined, all technical and scientific terms used herein have the meanings commonly understood by those skilled in the art. One skilled in the art will recognize many methods and materials similar or equivalent to those described herein that can be used to implement the present invention. Of course, the present invention is in no way limited to the methods and materials described.

[0023] The present invention provides a method for promoting the growth of probiotics, comprising: culturing the probiotics in a culture medium containing a fermentation product of a lactic acid bacteria strain combination, wherein the lactic acid bacteria strain combination comprises: Lactobacillus salivarius subsp.salicinius AP-32 (CCTCC No.M2011127), Lactobacillus plantarum LPL28 (CGMCC No.17954), Lactobacillus acidophilus TYCA06 (CGMCC No.15210), and Bifidobacterium longum subsp.infantis BLI-02 (CGMCC No.15212).

[0024] According to the present invention, the culture medium containing the fermentation product can be prepared by adding the fermentation product to a basal culture medium suitable for the growth of lactic acid bacteria. Preferably, the basal culture medium is added with 0.1-10wt% of the fermentation product, more preferably, 0.25-0.5wt% of the fermentation product. In a preferred embodiment of the present invention, the basal culture medium is added with 0.25wt% of the fermentation product. In another preferred embodiment of the present invention, the basal culture medium is added with 0.5wt% of the fermentation product.

[0025] According to the present invention, the basic culture medium suitable for the growth of lactic acid bacteria is well known to those skilled in the art and can be self-prepared or commercially available, including, but not limited to: MRS broth.

[0026] According to the present invention, the basal medium suitable for the present invention may contain a carbon source selected from the group consisting of glucose, fructose, lactose, sucrose, maltose, galactose, mannose, trehalose, starch, potato starch, malt extract, maltodextrin, and combinations thereof. Preferably, the basal medium contains 1-5wt% glucose. In a preferred embodiment of the present invention, the basal medium contains 5wt% glucose.

[0027] According to the present invention, the basal medium suitable for the present invention may contain a nitrogen source selected from the group consisting of: (NH4)2SO4, (NH4)3PO4, NH4NO3, NH4Cl, casaminoacid, peptone, polypeptone, tryptone, meat extract, yeast extract, yeast powder, milk, skim milk powder, soybean flour, whey, and combinations thereof. Preferably, the basal medium contains 2-15wt% skim milk powder, 3-10wt% peptone, and 1-5wt% yeast extract. In a preferred embodiment of the present invention, the basal medium contains 12wt% skim milk powder, 7wt% peptone, and 3wt% yeast extract.

[0028] As used herein, the terms "culturing", "fermentation" and "cultivation" are used interchangeably. The operating procedures and parameter conditions for culturing are within the professional qualities and routine skills of those skilled in the art. In this regard, reference may be made to, for example, Hsieh P Set al. (2013), New Microbiol., 36: 167-179.

[0029] According to the present invention, the culturing may be performed at a temperature ranging from 25° C. to 40° C. In a preferred embodiment of the present invention, the culturing is performed at 37° C.

[0030] According to the present invention, the culturing can be carried out for a period of time ranging from 6 to 12 hours. In a preferred embodiment of the present invention, the culturing is carried out for 6 hours.

[0031] According to the present invention, the fermentation product is a liquid culture obtained by culturing Lactobacillus salivarius AP-32, Lactobacillus plantarum LPL28, Lactobacillus acidophilus TYCA06 and Bifidobacterium longum subsp. infantis BLI-02 at a bacterial count ratio within the range of 1:0.2:0.2:0.2 to 1:5:5:5. In a preferred embodiment of the present invention, the bacterial count ratio of Lactobacillus salivarius AP-32, Lactobacillus plantarum LPL28, Lactobacillus acidophilus TYCA06 and Bifidobacterium longum subsp. infantis BLI-02 is 1:1:1:1.

[0032] According to the present invention, the culture medium and culture conditions suitable for the lactic acid bacteria strain combination are as described above.

[0033] According to the present invention, the liquid culture can be substantially free of bacterial cells by solid-liquid separation.

[0034] As used herein, the term "substantially free of" means that a specifically specified component lacks a meaningful amount. Preferably, the amount of the component has no measurable effect on the properties of the fermentation product of the lactic acid bacteria strain combination. More preferably, the fermentation product of the lactic acid bacteria strain combination does not contain the component at all.

[0035] According to the present invention, the solid-liquid separation treatment is selected from the group consisting of: centrifugation treatment, filtration treatment, concentration treatment, and combinations thereof. In a preferred embodiment of the present invention, the solid-liquid separation treatment is centrifugation treatment.

[0036] According to the present invention, the liquid culture may be further subjected to a drying process selected from the group consisting of freeze-drying, spray-drying, and fluidized bed drying to be in powder form.

[0037] As used herein, the terms "probiotics" and "probiotic microbes" are used interchangeably and refer to preparations of live microorganisms that, when ingested by a human or animal, can remain and survive in the gastrointestinal tract and are able to exert a desired effect.

[0038] According to the present invention, the probiotic can be selected from the group consisting of: Lactobacillus spp., Lactococcus spp., Pediococcus spp., Enterococcus spp., Streptococcus spp., Bifidobacterium spp., Bacillus spp., Leuconostoc spp., and combinations thereof.

[0039] Preferably, the Lactobacillus species is selected from the group consisting of Lactobacillus gasseri, Lactobacillus fermentum, Lactobacillus johnsonii, Lactobacillus reuteri, Lactobacillus helveticus, Lactobacillus casei, Lactobacillus paracasei, Lactobacillus rhamnosus, Lactobacillus delbrueckii, Lactobacillus bulgaricus, Lactobacillus salivarius, Lactobacillus plantarum, Lactobacillus acidophilus, and combinations thereof. In a preferred embodiment of the present invention, the Lactobacillus species is selected from the group consisting of: Lactobacillus gasseri AI-88, Lactobacillus gasseri LG21, Lactobacillus fermentum CECT5716, Lactobacillus johnsonii MH-68, Lactobacillus reuteri GL-104, Lactobacillus helveticus RE-78, Lactobacillus paracasei MP137, Lactobacillus paracasei ET-66, Lactobacillus rhamnosus MP108, Lactobacillus rhamnosus CT-53, Lactobacillus rhamnosus LGG, Lactobacillus plantarum LPL28, Lactobacillus plantarum TSP05, Lactobacillus acidophilus TYCA06 and Lactobacillus acidophilus LA-5.

[0040] Preferably, the Lactococcus species is Lactococcus lactis [eg, Lactococcus lactis subsp. lactis]. In a preferred embodiment of the present invention, the Lactococcus species is Lactococcus lactis subsp. lactis LY-66.

[0041] Preferably, the Streptococcus species is Streptococcus thermophilus. In a preferred embodiment of the present invention, the Streptococcus species is Streptococcus thermophilus SY-66 and Streptococcus thermophilus UASt-09.

[0042] Preferably, the Bifidobacterium species is selected from the group consisting of Bifidobacterium animalis [e.g., Bifidobacterium animalis subsp. lactis and Bifidobacterium animalis subsp. lactis Bb], Bifidobacterium breve, Bifidobacterium longum [e.g., Bifidobacterium longum infantis subsp.], Bifidobacterium bifidum, Bifidobacterium lactis, Bifidobacterium adolescentis, Bifidobacterium infantis, and combinations thereof. In a preferred embodiment of the present invention, the Bifidobacterium species is selected from the group consisting of Bifidobacterium animalis subsp. lactis CP-9, Bifidobacterium animalis subsp. lactis BB-12, Bifidobacterium animalis subsp. lactis BB-115, Bifidobacterium longum subsp. infantis BLI-02, Bifidobacterium breve Bv-889 and Bifidobacterium longum BB536.

[0043] Preferably, the probiotic is a combination of Lactobacillus species and Bifidobacterium species, for example, a combination of Lactobacillus rhamnosus, Bifidobacterium animalis and Bifidobacterium longum. In a preferred embodiment of the present invention, the probiotic is a combination of Lactobacillus rhamnosus MP108, Bifidobacterium animalis subsp. lactis BB-115 and Bifidobacterium longum subsp. infantis BLI-02.

[0044] The present invention also provides a method for producing probiotics, comprising: culturing the probiotics in a culture medium containing a fermentation product of a lactic acid bacteria strain combination as described above.

[0045] The present invention will be further described with reference to the following examples. However, it should be understood that these examples are only for illustration and should not be construed as limitations on the implementation of the present invention.

[0046] <Implementation Example>

[0047] General experimental materials:

[0048] 1. Fermentation medium:

[0049] The fermentation medium used in the following examples had a formulation as shown in Table 1 below.

[0050] Table 1. Formula of fermentation medium

[0051]

[0052] 2. Lactic acid bacteria strains:

[0053] The four lactic acid bacteria strains used for efficacy evaluation in the following examples have been disclosed in TW I709374B, among which Lactobacillus salivarius subsp.salicinius AP-32 has been disclosed in CN 102835666 B. These four lactic acid bacteria strains have been deposited in the Bioresource Collection and Research Center (BCRC) of the Food Industry Research and Development Institute (FIRDI) in Taiwan, China (No. 331, Food Road, Hsinchu City, Taiwan, China). In addition, these lactic acid bacteria strains have also been deposited in the China Center for Type Culture Collection (CCTCC) and the China General Microbiological Culture Collection Center (CGMCC) in accordance with the provisions of the Budapest Treaty. For clarity, the relevant information of each lactic acid bacteria strain (including scientific name, deposit number and deposit date, etc.) has been integrated into the following Table 2.

[0054] Table 2. Information about each lactic acid bacteria strain

[0055]

[0056] Note: Lactobacillus salivarius AP-32 and Lactobacillus acidophilus TYCA06 are publicly available.

[0057] 3. The various prebiotics and their sources used in the following examples have been integrated into Table 3 below.

[0058] Table 3. Sources of various prebiotics

[0059]

[0060] 4. Preparation of probiotic solution:

[0061] The probiotic strains used in the following examples and their sources have been compiled in Table 4 below.

[0062] Table 4. Various probiotic strains

[0063]

[0064]

[0065]

[0066] First, the above probiotic strains were inoculated into MRS broth (BD, Cat. No. DF0881-17-5) supplemented with 0.05% cysteine, and cultured in an incubator (37°C, 5% CO2) for 16 hours to activate the strains. Then, the activated strains were inoculated into MRS broth at an inoculum of 10% (v / v), and subcultured in an incubator (37°C, 5% CO2) for 24 hours. Afterwards, the resulting culture was adjusted to a concentration of 1×10 9 In addition, portions of the bacterial solutions of Lactobacillus rhamnosus MP108, Bifidobacterium animalis subsp. lactis BB-115, and Bifidobacterium longum subsp. infantis BLI-02 were taken and mixed at equal volumes (1:1:1) to obtain a mixed bacterial solution.

[0067] General experimental methods:

[0068] 1. Statistical analysis:

[0069] In the following examples, the experiments of each group were repeated 3 times, and the experimental data were expressed as "mean ± standard error of the mean (SEM). All data were analyzed by two-tailed Student's t-test to evaluate the differences between the groups. If the statistical analysis results obtained were p < 0.05, it indicated statistical significance.

[0070] Example 1. Preparation of lactic acid bacteria fermentation products:

[0071] First, the four lactic acid bacteria strains described in item 2 of the above "General Experimental Materials" were inoculated into 100 mL of the fermentation medium described in item 1 of the above "General Experimental Materials" and cultured at 37°C for 24 hours to activate the strains. 9 CFU / mL) were inoculated into 5 L of fermentation medium at an inoculum amount of 3% (v / v), and fermentation culture was carried out under anaerobic conditions at 37° C. overnight to obtain fermentation cultures of the four lactic acid bacteria strains.

[0072] In addition, the activated lactic acid bacteria strain cultures were mixed according to the ratios shown in Table 5 to obtain 5 lactic acid bacteria strain combinations (i.e., strain combinations 1 to 5), and were inoculated into 5 L of fermentation medium at an inoculation amount of 3% (v / v), and fermented under anaerobic conditions at 37°C for overnight, thereby obtaining fermentation cultures of strain combinations 1 to 5.

[0073] Thereafter, the fermentation cultures of the four lactic acid bacteria strains and the combination of the five strains were centrifuged to precipitate the bacteria, and the supernatant was collected and subjected to heat sterilization and spray-drying treatment in sequence, thereby obtaining a powdered lactic acid bacteria fermentation product.

[0074] Table 5. Ratio of bacterial count used in each strain combination

[0075] Strain combination AP-32: LPL28: TYCA06: BLI-02 1 1:0.2:0.2:0.2 2 1:1:1:1 3 1:5:1:1 4 1:1:5:1 5 1:1:1:5

[0076] Example 2. Evaluation of the effectiveness of lactic acid bacteria fermentation products in promoting the growth of probiotics

[0077] Experimental methods:

[0078] First, the 9 lactic acid bacteria fermentation products obtained in Example 1 above were respectively prepared in 4.5 mL of fermentation medium at a content of 0.5 wt %, and then the bacterial solution of Lactobacillus rhamnosus MP108 obtained in Item 4 of the above "General Experimental Materials" was divided into 4 single bacteria comparison groups (i.e., single bacteria comparison groups 1 to 4), 5 composite bacteria experimental groups (i.e., composite bacteria experimental groups 1 to 5) and 1 control group (each group was 5 μL), and the bacterial solution of each single bacteria comparison group and the composite bacteria experimental group was inoculated into the fermentation medium containing different lactic acid bacteria fermentation products as shown in Table 6 below, while the bacterial solution of the control group was inoculated into the fermentation medium without any lactic acid bacteria fermentation products, and then cultured at 37° C. for 6 hours.

[0079] Table 6. Lactic acid bacteria fermentation products contained in the fermentation medium inoculated in each group

[0080] Group Lactic acid fermentation products Single bacteria comparison group 1 Lactobacillus salivarius AP-32 Single bacteria comparison group 2 Lactobacillus plantarum LPL28 Single bacteria comparison group 3 Lactobacillus acidophilus TYCA06 Single bacteria comparison group 4 Bifidobacterium longum subsp. infantis BLI-02 Composite bacteria experimental group 1 Strain combination 1 Compound bacteria experimental group 2 Strain combination 2 Compound bacteria experimental group 3 Strain combination 3 Compound bacteria experimental group 4 Strain combination 4 Compound bacteria experimental group 5 Strain combination 5 Control group -

[0081] Then, 0.02 mL of the fermentation culture obtained from each group was taken and the absorbance (OD 600 In addition, a fermentation medium without inoculation of bacterial liquid and without any lactic acid bacteria fermentation product was used as a blank control group, and the absorbance value (OD 600 ).

[0082] The relative growth multiple of each group of Lactobacillus rhamnosus MP108 was calculated by measuring the absorbance value (OD 600 ) is substituted into the following formula (I) and calculated:

[0083] Formula (I): A = (B - D) / (C - D)

[0084] Where: A = relative growth multiple

[0085] B = OD measured in each group 600 Absorbance

[0086] C = OD measured in the control group 600 Absorbance

[0087] D = OD measured in the blank control group 600 Absorbance

[0088] Afterwards, the experimental data obtained were analyzed according to the method described in the first item "Statistical analysis" of the "General experimental methods" above.

[0089] result:

[0090] The results are displayed in Figure 1 In. By Figure 1 It can be seen that compared with the control group, the relative growth multiples of the single bacteria comparison groups 1 to 4 were not significantly different, while the relative growth multiples of the compound bacteria experimental groups 1 to 5 were significantly increased, and the increase in the multiple of the compound bacteria experimental group 2 was even higher than that of the other compound bacteria experimental groups. This experimental result shows that the combined use of the fermentation products of Lactobacillus salivarius AP-32, Lactobacillus plantarum LPL28, Lactobacillus acidophilus TYCA06 and Bifidobacterium longum subsp. infantis BLI-02 can synergistically promote the growth of Lactobacillus rhamnosus MP108.

[0091] Example 3. Evaluation of the effectiveness of fermentation products of lactic acid bacteria strain combinations in promoting the growth of different probiotics

[0092] To further evaluate whether the fermentation product containing the strain combination of Lactobacillus salivarius AP-32, Lactobacillus plantarum LPL28, Lactobacillus acidophilus TYCA06 and Bifidobacterium longum subsp. infantis BLI-02 can also be used to promote the growth of other probiotics, the following experiment was performed.

[0093] Experimental methods:

[0094] First, the lactic acid bacteria fermentation product of strain combination 2 obtained in Example 1 above was prepared in 4.5 mL of fermentation medium at a content of 0.5 wt%. Next, each probiotic bacterial solution obtained in item 4 of the "General Experimental Materials" above was divided into a composite bacterial group and a control group (each group was 5 μL). The probiotic bacterial solution of the composite bacterial group was then inoculated into the fermentation medium containing the lactic acid bacteria fermentation product of strain combination 1, while the bacterial solution of the control group was inoculated into the fermentation medium without any lactic acid bacteria fermentation product, and then cultured at 37°C for 6 hours. Afterwards, the relative growth multiple was determined and the data analyzed according to the method described in Example 2.

[0095] result:

[0096] The results are shown in Table 7 below. As can be seen from Table 7, the relative growth multiples of each Lactobacillus, Lactococcus, Streptococcus and Bifidobacterium strain were significantly increased compared with the control group. This experimental result shows that the combined use of fermentation products of Lactobacillus salivarius AP-32, Lactobacillus plantarum LPL28, Lactobacillus acidophilus TYCA06 and Bifidobacterium longum subsp. infantis BLI-02 can effectively promote the growth of probiotics of various strains.

[0097] Table 7. Relative growth multiples of different probiotics promoted by lactic acid bacteria fermentation products

[0098] Probiotics Relative growth multiple Lactobacillus gasseri AI-88 1.62±0.11*** Lactobacillus gasseri LG21 1.15±0.01** Lactobacillus fermentum CECT5716 1.46±0.05*** Lactobacillus johnsonii MH-68 1.31±0.07** Lactobacillus reuteri GL-104 1.39±0.02*** Lactobacillus helveticus RE-78 1.42±0.09** Lactobacillus paracasei MP137 1.17±0.05** Lactobacillus paracasei ET-66 1.27±0.04*** Lactobacillus rhamnosus CT-53 1.28±0.11** Lactobacillus rhamnosus MP108 1.34±0.03*** Lactobacillus rhamnosus LGG 1.15±0.03* Lactobacillus plantarum LPL28 1.26±0.05** Lactobacillus plantarum TSP05 1.21±0.25* Lactobacillus acidophilus TYCA06 1.64±0.04** Lactobacillus acidophilus LA-5 1.77±0.01** Lactococcus lactis subsp. lactis LY-66 1.16±0.04* Streptococcus thermophilus SY-66 1.33±0.04*** Streptococcus thermophilus UASt-09 1.20±0.03** Bifidobacterium animalis subsp. lactis BB-115 1.13±0.03** Bifidobacterium animalis subsp. lactis CP-9 1.12±0.03** Bifidobacterium animalis subsp. lactis BB-12 1.27±0.07** Bifidobacterium longum subsp. infantis BLI-02 1.29±0.04** Bifidobacterium breve Bv-889 1.21±0.04* Bifidobacterium longum BB536 1.49±0.05***

[0099] Note: “*”, “**” and “***” respectively indicate p<0.05, p<0.01 and p<0.001 when compared with the control group.

[0100] Example 4. Comparison of the effectiveness of fermentation products of lactic acid bacteria strain combinations and conventional prebiotics in promoting the growth of probiotics

[0101] Experimental methods:

[0102] First, the six prebiotics described in item 3 of the above “General Experimental Materials” and the lactic acid bacteria fermentation product of strain combination 2 obtained in Example 1 above were added to 4.5 mL of fermentation medium at contents of 0.25 wt % and 0.5 wt %, respectively. Next, the bacterial solution of Lactobacillus rhamnosus MP108 obtained in item 4 of the above "General Experimental Materials" was divided into 2 human milk oligosaccharide groups (i.e., human milk oligosaccharide X1 group and X2 group), 2 maltodextrin groups (i.e., maltodextrin X1 group and X2 group), 2 fructooligosaccharide groups (i.e., fructooligosaccharide X1 group and X2 group), 2 galacto-oligosaccharide groups (i.e., galacto-oligosaccharide X1 group and X2 group), 2 sorbitol groups (i.e., sorbitol X1 group and X2 group), 2 erythritol groups (i.e., erythritol X1 group and X2 group), 2 inulin groups (i.e., inulin X1 group and X2 group), 2 composite bacteria groups (i.e., composite bacteria X1 group and X2 group), and 2 control groups (i.e., control X1 group and X2 group), each group having 5 μL. Then, the Lactobacillus rhamnosus MP108 bacterial solution of each group was inoculated into a fermentation medium containing a prebiotic or lactic acid bacteria fermentation product having a corresponding concentration (0.25wt% and 0.5wt% for Group X1 and Group X2, respectively), while the bacterial solution of the control group was inoculated into a fermentation medium without any lactic acid bacteria fermentation product, and then cultured at 37° C. for 6 hours. Thereafter, the relative growth multiples of Lactobacillus rhamnosus MP108 of each group were determined and the data were analyzed by referring to the method described in Example 2.

[0103] In addition, in order to understand the effectiveness of the lactic acid bacteria fermentation product of the strain combination used in the present invention in promoting the growth of other probiotics or mixed multiple probiotics compared to conventional prebiotics, an experiment was conducted with reference to the method described above for Lactobacillus rhamnosus MP108, except that the bacterial solution of Bifidobacterium animalis subsp. lactis CP-9 and the mixed bacterial solution obtained in item 4 of the above "General Experimental Materials" were used instead of the bacterial solution of Lactobacillus rhamnosus MP108.

[0104] result:

[0105] The results are displayed in Figures 2 to 4 In. By Figures 2 to 4 It can be seen that, whether for Lactobacillus rhamnosus MP108, Bifidobacterium animalis subsp. lactis CP-9, or mixed probiotics, various conventional prebiotics may not necessarily be able to effectively promote the growth of probiotics. In contrast, the fermentation products containing the strain combination of Lactobacillus salivarius AP-32, Lactobacillus plantarum LPL28, Lactobacillus acidophilus TYCA06, and Bifidobacterium longum subsp. infantis BLI-02 can significantly promote growth.

[0106] The experimental results show that the fermentation products of Lactobacillus salivarius AP-32, Lactobacillus plantarum LPL28, Lactobacillus acidophilus TYCA06 and Bifidobacterium longum infantis subsp. BLI-02 can effectively promote the growth of one or more probiotics at different concentrations and can be used to replace conventional prebiotics. All patents and documents cited in this specification are incorporated herein by reference in their entirety. In the event of any conflict, the detailed description (including definitions) of this case shall prevail.

[0107] Although the present invention has been described with reference to the specific embodiments above, it is apparent that many modifications and variations can be made without departing from the scope and spirit of the invention. It is therefore intended that the present invention be limited only as indicated by the appended claims.

[0108] Information on the deposit of biological materials

[0109] Deposit number: CCTCC No.M 2011127

[0110] Taxonomic nomenclature: Lactobacillus salivarius subsp.salicinius AP-32

[0111] Date of deposit: April 10, 2011

[0112] Collection Unit: China Center for Type Culture Collection

[0113] Address of depository: Wuhan University, Wuhan, China

[0114] Information on the deposit of biological materials

[0115] Deposit number: CGMCC No.17954

[0116] Classification and nomenclature: Lactobacillus plantarum LPL28

[0117] Date of deposit: June 18, 2019

[0118] Depository: China National Microbiological Culture Collection Administration General Microbiology Center

[0119] Address of the depository: No. 3, Yard 1, Beichen West Road, Chaoyang District, Beijing

[0120] Information on the deposit of biological materials

[0121] Deposit number: CGMCC No.15210

[0122] Classification name: Lactobacillus acidophilus TYCA06

[0123] Date of deposit: January 15, 2018

[0124] Depository: China National Microbiological Culture Collection Administration General Microbiology Center

[0125] Address of the depository: No. 3, Yard 1, Beichen West Road, Chaoyang District, Beijing

[0126] Information on the deposit of biological materials

[0127] Deposit number: CGMCC No.15212

[0128] Classification name: Bifidobacterium longum subsp. infantis BLI-02

[0129] Date of deposit: January 15, 2018

[0130] Depository: China National Microbiological Culture Collection Administration General Microbiology Center

[0131] Address of the depository: No. 3, Yard 1, Beichen West Road, Chaoyang District, Beijing

Claims

1. A method for promoting the growth of probiotics, characterized in that: The probiotics are cultured in a culture medium containing a fermentation product of a lactic acid bacteria strain combination, wherein the lactic acid bacteria strain combination is Lactobacillus salivarius subsp.salicinius AP-32 with a preservation number of CCTCC NO.M2011127, Lactobacillus plantarum LPL28 with a preservation number of CGMCC NO.17954, Lactobacillus acidophilus TYCA06 with a preservation number of CGMCC NO.15210, and Bifidobacterium longum subsp. infantis with a preservation number of CGMCC NO.15212.infantis) BLI-02, the fermentation product is a liquid culture that is substantially free of bacterial cells after solid-liquid separation treatment, and the probiotic is selected from the group consisting of: Lactobacillus gasseri, Lactobacillus fermentum, Lactobacillus johnsonii, Lactobacillus reuteri, Lactobacillus helveticus, Lactobacillus casei, Lactobacillus paracasei, Lactobacillus rhamnosus, Lactobacillus delbrueckii, Lactobacillus bulgaricus, Lactobacillus salivarius, Lactobacillus plantarum, Lactobacillus salivarius ... plantarum, Lactobacillus acidophilus, Lactococcus lactis, Streptococcus thermophilus, Bifidobacterium animalis, Bifidobacterium breve, Bifidobacterium longum, Bifidobacterium bifidum, Bifidobacterium lactis, Bifidobacterium adolescentis, Bifidobacterium infantis, and combinations thereof.

2. The method according to claim 1, characterized in that: The fermentation product is a liquid culture prepared by culturing Lactobacillus salivarius subsp.salicinius AP-32, Lactobacillus plantarum LPL28, Lactobacillus acidophilus TYCA06 and Bifidobacterium longum subsp. infantis BLI-02 with a bacterial count ratio within a range of 1:0.2:0.2:0.2 to 1:5:5:

5.

3. The method according to claim 2, characterized in that: The bacterial count ratio is 1:1:1:1.